Last Updated: September 28, 2026

Litigation Details for Sonos, Inc. v. Google LLC (N.D. Cal. 2021)


✉ Email this page to a colleague

« Back to Dashboard


Sonos, Inc. v. Google LLC (N.D. Cal. 2021)

Docket 3:21-cv-07559 Date Filed 2021-09-28
Court District Court, N.D. California Date Terminated 2023-10-10
Cause 35:271 Patent Infringement Assigned To William Haskell Alsup
Jury Demand Plaintiff Referred To Thomas S. Hixson
Patents 12,194,008; 9,056,052; 9,200,002
Link to Docket External link to docket
Small Molecule Drugs cited in Sonos, Inc. v. Google LLC
The small molecule drugs covered by the patents cited in this case are ⤷  Start Trial and ⤷  Start Trial .

Sonos, Inc. v. Google LLC, Case No. 3:21-cv-07559: Litigation Summary and Patent Analysis

Last updated: August 9, 2026

Sonos won a jury verdict against Google in the Northern District of California in 2023. The jury found that Google infringed Sonos patents covering multiroom audio and awarded Sonos approximately $32.5 million. The case is part of a broader patent dispute involving parallel district-court litigation, an International Trade Commission investigation, product redesigns, and competing infringement claims.

What is Sonos v. Google, 3:21-cv-07559?

Sonos filed the action against Google on September 24, 2021, in the U.S. District Court for the Northern District of California. The case was assigned to Judge William H. Orrick and alleges that Google products infringe Sonos patents relating to wireless speaker systems, synchronized playback, speaker grouping, and control of multiple networked audio devices.

The accused products included Google Home, Nest, Chromecast, Pixel, and related software and services. Sonos sought damages, enhanced damages for willful infringement, attorneys' fees, and injunctive relief.

The case followed an earlier Sonos-initiated dispute that produced an ITC exclusion order against certain Google products. The 2021 district-court complaint expanded the dispute and pursued monetary relief unavailable through the ITC proceeding.

Case profile

Item Details
Court U.S. District Court for the Northern District of California
Case number 3:21-cv-07559
Judge William H. Orrick
Plaintiff Sonos, Inc.
Defendant Google LLC
Filing date September 24, 2021
Technology Wireless multiroom audio, speaker grouping, synchronized playback
Trial result Jury verdict for Sonos
Damages Approximately $32.5 million
Principal commercial products Google Home, Nest, Chromecast, Pixel and related services

What patents did Sonos assert against Google?

Sonos asserted a portfolio of patents derived from technology developed for synchronized multiroom audio systems. Public case reporting and court filings identify the following patents as central to the litigation:

Patent Subject matter associated with the dispute
U.S. Patent No. 9,967,615 Wireless speaker control and multi-device audio coordination
U.S. Patent No. 10,469,966 Synchronization and coordinated playback
U.S. Patent No. 10,795,033 Networked speaker control and audio-system configuration
U.S. Patent No. 10,848,885 Multiroom audio control and speaker grouping
U.S. Patent No. 11,038,413 Networked audio-device operation and control

The patents trace priority to earlier Sonos technology filings. The asserted claims generally address how a system discovers networked devices, assigns devices to groups, coordinates playback, and allows a user to control several speakers through a common interface.

What technology was at issue?

The dispute concerned functions that are commercially important to smart-speaker platforms:

  • Creating or modifying a group of speakers.
  • Synchronizing audio playback across multiple devices.
  • Maintaining playback when devices join or leave a group.
  • Assigning roles to networked speakers.
  • Controlling the group through a mobile application or other interface.
  • Coordinating volume and playback state across devices.

Sonos argued that Google copied core architectural concepts used in Sonos wireless speaker products. Google disputed infringement and challenged the validity and scope of the asserted claims.

What did the jury decide in Sonos v. Google?

The 2023 jury trial resulted in a verdict for Sonos. The jury found that Google infringed Sonos patents covering multiroom audio functionality and awarded approximately $32.5 million in damages.

The verdict was materially smaller than the damages amount Sonos had sought. Sonos had pursued a larger recovery based on the volume of Google products and services allegedly using the patented technology.

The jury verdict did not automatically create a broad prohibition on Google products. Monetary damages and injunctive relief are separate remedies. The scope of any post-verdict relief depended on the judgment, post-trial motions, and appellate proceedings.

Damages analysis

The award was significant for Sonos but modest relative to Google’s product revenues. Its commercial effect was greater as a validation of Sonos’s patent position than as a direct financial burden on Google.

The damages calculation was linked to the accused products and the jury’s determination of a reasonable royalty. The verdict did not establish that every Google smart-home product infringed every Sonos patent. It applied to the claims and products presented at trial.

Which patents were involved in the verdict?

Public reporting identified the verdict as involving Sonos patents directed to the operation of groups of networked speakers, including U.S. Patent Nos. 10,469,966 and 10,848,885. The litigation also involved other Sonos patents, but a complaint-level assertion does not mean that each asserted patent reached a liability verdict.

The practical distinction is important:

  1. Sonos’s broader patent estate covered multiple technical features.
  2. The jury’s liability finding was limited to the claims and products submitted to the jury.
  3. The damages award did not establish infringement of every patent in the portfolio.
  4. Google retained validity, noninfringement, and remedy arguments through post-trial and appellate proceedings.

What was Google’s defense?

Google contested both infringement and patent validity. Its defenses included arguments that:

  • The accused Google products did not practice the asserted claim limitations.
  • Sonos’s patents were invalid in view of prior art.
  • The asserted claims should be narrowly construed.
  • Sonos’s damages theory overstated the value of the patented features.
  • Certain functionality could be removed or redesigned without eliminating the overall product offering.

Google also argued that Sonos had relied on technology developed in the course of a commercial relationship between the companies. Google maintained that its products were independently developed and that Sonos’s patents should not reach broad categories of wireless audio functionality.

The validity defenses were commercially important because a finding of invalidity would have eliminated future enforcement leverage, including against new Google product generations and potential third-party licensees.

How does the case relate to the earlier ITC investigation?

The district-court case followed an ITC proceeding initiated by Sonos. In Investigation No. 337-TA-1191, the ITC found that certain Google products infringed Sonos patents and issued a limited exclusion order in January 2022. The order restricted importation of infringing products into the United States.

The ITC matter and the district-court case served different purposes:

Issue ITC proceeding District-court action
Primary remedy Import exclusion Damages and potential injunction
Defendant Google Google
Forum International Trade Commission Northern District of California
Commercial effect U.S. import restrictions Monetary liability and equitable relief
Key risk Product entry and supply chain Damages, licensing and product redesign

Google changed certain product functions after the ITC ruling. Google stated that it could redesign its products to avoid the asserted Sonos technology. Sonos disputed whether those changes eliminated infringement concerns and argued that Google’s redesigns reduced functionality for consumers.

Did Google redesign its products after the Sonos patent ruling?

Yes. Google implemented software and user-interface changes after the ITC exclusion order. The changes affected speaker-group controls, volume management, and certain multi-device functions.

Reported changes included:

  • Removing or modifying group-volume controls.
  • Requiring users to adjust speakers individually in some circumstances.
  • Changing device setup and control flows.
  • Altering the operation of speaker groups and synchronized playback.

The redesign dispute illustrates the commercial scope of Sonos’s patents. If a patented feature is central to the user experience, a workaround may avoid infringement while reducing product functionality. If the feature is peripheral, the accused company may remove it with limited revenue impact.

What patent litigation did Google bring against Sonos?

Google filed counterclaims and separate claims against Sonos during the broader dispute. Google accused Sonos of infringing Google patents relating to smart speakers and connected-home technology.

Google’s claims increased litigation pressure on Sonos and created potential exposure involving:

  • Sonos wireless speakers.
  • Voice-assistant functionality.
  • Speaker control and device configuration.
  • Connected-home interoperability.
  • Wireless communications and network management.

The reciprocal litigation reduced the likelihood of a simple one-sided injunction. Both companies faced risks involving product redesign, licensing, damages, and adverse precedent.

Was there a settlement agreement between Sonos and Google?

The publicly reported district-court litigation proceeded through trial and a jury verdict rather than ending in a pretrial settlement. The case should be distinguished from commercial agreements between the companies and from later disputes involving other patents or products.

No broad cross-license can be inferred from the parties’ commercial relationship. Sonos and Google continued to litigate despite earlier cooperation involving Google services and Sonos products.

A settlement would likely have addressed several issues at once:

  • Monetary compensation.
  • Continued Google use of Sonos technology.
  • Google’s counterclaims.
  • Sonos product exposure to Google patents.
  • Product redesign obligations.
  • Future patent enforcement rights.

What is the litigation status and appeal risk?

The jury verdict established liability and damages at the trial level, but post-trial motions and appellate review remained important. Google had incentives to challenge:

  • Claim construction.
  • Sufficiency of the infringement evidence.
  • Patent validity.
  • Damages methodology.
  • The availability and scope of injunctive relief.
  • The effect of product redesigns on ongoing infringement.

Sonos, in turn, had incentives to seek stronger post-verdict remedies and preserve its ability to assert related patents against later Google products.

The principal litigation risk for Google was not the $32.5 million payment alone. It was the possibility that the verdict could support further licensing demands or additional lawsuits involving updated products using substantially similar architecture.

How strong is Sonos’s patent estate against Google?

Sonos’s estate was relatively strong in three respects.

Patent-family depth

Sonos asserted multiple patents with overlapping technical themes. A defendant that defeats one patent may still face claims from related patents covering synchronization, grouping, configuration, or control.

Commercial relevance

The patents addressed functions central to the multiroom speaker experience. That gave Sonos leverage beyond the value of any single patent.

ITC validation

The ITC’s finding of infringement and exclusion order strengthened Sonos’s negotiating position. An ITC remedy does not determine district-court damages, but it creates supply-chain and product-entry risk.

The estate also had limitations. Many patents in the portfolio originated from earlier priority filings, creating expiration and prior-art risks. Overlapping patent claims can create prosecution-history and claim-construction issues. Software-related patents also face detailed infringement analyses that depend on implementation evidence.

When do Sonos’s asserted patents expire?

The asserted patents generally have terms calculated from their earliest effective nonprovisional filing dates, subject to patent-term adjustment and any applicable patent-term extension. Because the patents derive from earlier Sonos filings, their expiration dates may occur before the nominal 20-year term measured from the later grant date suggests.

The commercially relevant point is that the patents were approaching the later part of their enforceable terms during the 2021-2023 litigation. This compressed the period in which Sonos could obtain forward-looking relief and increased the importance of damages, licensing, and enforcement against successor products.

Exact expiration analysis requires reviewing each patent’s continuity data, terminal disclaimers, patent-term adjustment, and priority chain. The patent numbers, grant dates, and family relationships are available through the USPTO Patent Center and Google Patents records. [USPTO, n.d.; Google Patents, n.d.]

What generic or biosimilar risks exist in this case?

Traditional generic-drug and biosimilar frameworks do not apply. This is a device and software patent dispute, not an FDA Hatch-Waxman or biologics litigation.

There was no Orange Book listing, Paragraph IV certification, abbreviated new drug application, or biosimilar interchangeability issue. The relevant market-entry risks were:

  • Product importation.
  • Software deployment.
  • Firmware updates.
  • App functionality.
  • Hardware redesign.
  • Licensing and royalty obligations.

The FDA had no material regulatory role in the dispute. The operative legal venues were the federal district court, the ITC, and potentially the Federal Circuit.

What are the commercial implications for Sonos and Google?

For Sonos, the verdict created potential licensing leverage and supported enforcement against other connected-audio companies. It also validated Sonos’s strategy of protecting user-interface and system-level audio functions rather than relying only on hardware patents.

For Google, the immediate financial exposure was limited relative to company revenue, but the product risk was broader. Google had to manage:

  • Feature reductions.
  • Engineering costs.
  • User-experience degradation.
  • Ongoing patent assertions.
  • Potential royalty payments.
  • Risk involving future hardware generations.

The case also affected competitors such as Amazon, Bose, Apple, Samsung, and other manufacturers of connected speakers. Sonos’s patents could be used as licensing assets or litigation tools against products with similar multiroom functionality, although infringement would require a product-specific claim analysis.

Key Takeaways

  • Sonos sued Google in Case No. 3:21-cv-07559 on September 24, 2021.
  • The dispute concerned synchronized playback, speaker grouping, wireless control, and multiroom audio.
  • Sonos asserted a portfolio that included U.S. Patent Nos. 9,967,615, 10,469,966, 10,795,033, 10,848,885, and 11,038,413.
  • A 2023 jury found Google liable for infringement and awarded approximately $32.5 million.
  • The case followed an ITC proceeding that produced a limited exclusion order against certain Google products.
  • Google redesigned some product functions after the ITC ruling.
  • The dispute involved broader reciprocal claims and was not a conventional generic-drug or biosimilar case.
  • The main commercial risks were product redesign, licensing, damages, import restrictions, and future enforcement against updated platforms.

FAQs

Could Sonos obtain an injunction against Google products?

An injunction was legally possible but not automatic. The court would have to evaluate infringement, patent validity, irreparable harm, the balance of hardships, and the public interest. The ITC exclusion order created import-related pressure but did not itself mandate a district-court product injunction.

Did the verdict cover all Google Home and Nest products?

No. Patent verdicts apply to the claims, products, and technical implementations presented to the jury. Product families using different software or hardware versions may require separate infringement analysis.

Can Google avoid Sonos patents through software updates?

Potentially. A software or firmware redesign can avoid infringement if it removes the claim limitations identified by the court or jury. A workaround that preserves the same patented process may remain exposed.

Does the case affect Amazon Echo or Apple HomePod products?

Not automatically. The verdict applies to Google and the accused implementations. Other products may raise similar technical issues, but each product must be mapped against the asserted patent claims.

Are Sonos patents listed in the FDA Orange Book?

No. Sonos’s patents are not pharmaceutical patents and are not Orange Book-listed drug patents. The Orange Book and Paragraph IV procedures have no direct role in this litigation.

References

Google Patents. (n.d.). U.S. patent records for Sonos asserted patents. https://patents.google.com/

International Trade Commission. (2022). Certain audio players and components thereof, Investigation No. 337-TA-1191. https://www.usitc.gov/

Sonos, Inc. v. Google LLC, No. 3:21-cv-07559, U.S. District Court for the Northern District of California.

U.S. District Court for the Northern District of California. (2023). Sonos, Inc. v. Google LLC, Case No. 3:21-cv-07559 docket materials. https://ecf.cand.uscourts.gov/

U.S. Patent and Trademark Office. (n.d.). Patent Center. https://patentcenter.uspto.gov/

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.